Awakening a Millennium of Tibetan Medicine's Potential — Charting a New
Era of Global Health
Milestones
Leadership
Geng Jun
Chairman & President
Founder, Arura Group
Geng Jun
Chairman & President
Founder, Arura Group
Mr. Geng Jun previously served as Vice President of China
CYTS Tours Holding Co., Ltd. (SSE: 600138), accumulating 15
years of expertise in cultural tourism. He later assumed the
role of General Manager at Tibet Cheezheng Tibetan Medicine
Co., Ltd. (SZSE: 002287), dedicating 25 years to advancing
Tibetan medicine.
Zhang Yizhi
Executive Director, Executive President & Chief Science Officer
Zhang Yizhi
Executive Director, Executive President & Chief Science
Officer
With over 20 years of dedicated expertise in Tibetan
medicine, Mr. Zhang Yizhi is a Professor-level Senior
Engineer and holds a Master's degree in Pharmaceutical
Informatics from Nanjing University. He has spearheaded the
development of 30+ innovative drugs (with certification
approvals) and led 10+ national/provincial-level key
research projects, while holding 25 patents.
Jia Xuejiao
Chief Financial Officer
Jia Xuejiao
Chief Financial Officer
Ms. Jia Xuejiao has focused on the Tibetan medicine sector
for over a decade. She holds dual bachelor's degrees in
Economics and Management from East China University of
Science and Technology, and has held core roles in finance,
audit, and marketing. She excels at driving enterprise value
through business-finance integration, with extensive
experience in strategic financial planning, cost control,
and operational efficiency optimization.
Chen Peilin
Company Secretary
Chen Peilin
Company Secretary
Ms. Chen Peilin holds a Bachelor of Laws from Central
University of Finance and Economics and an LL.M from the
University of Southern California. With prior experience at
Commerce & Finance Law Offices, she specializes in private
equity/venture capital, corporate financing & restructuring,
and cross-border listings. She has provided legal services
to renowned investment institutions, startups, and listed
companies across medical devices, cosmetics, and TMT
sectors.